(S (S (VP (VBG Minimizing) (NP (NP (JJ adverse) (NNS reactions)) (VP (VBN caused) (PP (IN by) (NP (NML (NN drug) (HYPH -) (NN drug)) (NNS interactions))))))) (VP (VBZ has) (ADVP (RB always)) (VP (VBN been) (NP (NP (DT a) (JJ momentous) (NN research) (NN topic)) (PP (IN in) (NP (JJ clinical) (NN pharmacology)))))) (. .))
(S (S (VP (VBG Detecting) (NP (DT all) (JJ possible) (NNS interactions)) (PP (IN through) (NP (JJ clinical) (NNS studies))) (SBAR (IN before) (S (NP (DT a) (NN drug)) (VP (VBZ is) (VP (VBN released) (PP (IN to) (NP (DT the) (NN market))))))))) (VP (VBZ is) (NP (DT a) (JJ demanding) (NN task))) (. .))
(S (NP (NP (DT The) (NN power)) (PP (IN of) (NP (JJ big) (NNS data)))) (VP (VBZ is) (VP (VBG opening) (PRT (RP up)) (NP (JJ new) (NNS approaches)) (S (VP (TO to) (VP (VB discover) (NP (JJ various) (NML (NN drug) (HYPH -) (NN drug)) (NNS interactions))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (DT these) (NNS discoveries)) (VP (VP (VBP contain) (NP (NP (DT a) (JJ huge) (NN amount)) (PP (IN of) (NP (NN noise))))) (CC and) (VP (VB provide) (NP (NN knowledge) (NNS bases)) (ADVP (RB far) (PP (IN from) (NP (ADJP (JJ complete) (CC and) (JJ trustworthy)) (NNS ones)))) (S (VP (TO to) (VP (VB be) (VP (VBN utilized))))))) (. .))
(S (NP (ADJP (JJS Most) (VBG existing)) (NNS studies)) (VP (VP (VBP focus) (PP (IN on) (S (VP (VBG predicting) (NP (NP (JJ binary) (NML (NN drug) (HYPH -) (NN drug)) (NNS interactions)) (PP (IN between) (NP (NN drug) (NNS pairs)))))))) (CC but) (VP (VB ignore) (NP (JJ other) (NNS interactions)))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (S (NP (NP (DT a) (JJ novel) (NN framework)) (, ,) (VP (VBN called) (NP (NN PRD))) (, ,)) (VP (TO to) (VP (VB predict) (NP (NML (NN drug) (HYPH -) (NN drug)) (NNS interactions)))))) (. .))
(S (NP (DT The) (NN framework)) (VP (VBZ uses) (NP (NP (DT the) (NN graph) (NN embedding)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB overcome) (NP (NP (NNS data) (NN incompleteness)) (CC and) (NP (NN sparsity) (NNS issues))) (S (VP (TO to) (VP (VB achieve) (NP (NML (JJ multiple) (NNP DDI)) (NN label) (NN prediction))))))))))) (. .))
(S (ADVP (RB First)) (, ,) (NP (DT a) (NML (JJ large) (HYPH -) (NN scale)) (NN drug) (NN knowledge) (NN graph)) (VP (VBZ is) (VP (VBN generated) (PP (IN from) (NP (JJ different) (NNS sources))))) (. .))
(S (ADVP (RB Then)) (, ,) (NP (DT the) (NN knowledge) (NN graph)) (VP (VBZ is) (VP (VBN embedded) (PP (IN with) (NP (JJ comprehensive) (JJ biomedical) (NN text))) (PP (IN into) (NP (DT a) (JJ common) (ADJP (JJ low) (JJ dimensional)) (NN space))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (DT the) (NML (S (VP (VBN learned)))) (NNS embeddings)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (ADVP (RB efficiently)) (VP (VB compute) (NP (JJ rich) (NNP DDI) (NN information)) (PP (IN through) (NP (DT a) (NN link) (NN prediction) (NN process)))))))) (. .))
(S (S (VP (TO To) (VP (VB validate) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT the) (VBN proposed) (NN framework))))))) (, ,) (NP (JJ extensive) (NNS experiments)) (VP (VBD were) (VP (VBN conducted) (PP (IN on) (NP (NML (JJ real) (HYPH -) (NN world)) (NNS datasets))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (PRP$ our) (NN model)) (VP (VBZ outperforms) (NP (JJ several) (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NN baseline) (NNS methods)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN capability) (CC and) (NN accuracy))))))))) (. .))
